• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 5. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511

Introduction to (±)-α-Tocopherol nicotinate (CAS No. 51898-34-1)

(±)-α-Tocopherol nicotinate, identified by the Chemical Abstracts Service Number (CAS No.) 51898-34-1, is a synthetic derivative of vitamin E that has garnered significant attention in the field of pharmaceuticals and nutraceuticals. This compound is particularly recognized for its enhanced bioavailability and improved solubility compared to its parent compound, α-tocopherol. The combination of vitamin E's well-documented antioxidant properties with the lipophilic and metabolic benefits of nicotinic acid (niacin) makes (±)-α-tocopherol nicotinate a promising candidate for various therapeutic applications.

The chemical structure of (±)-α-tocopherol nicotinate consists of a tocopherol backbone esterified with nicotinic acid. This modification enhances the compound's ability to cross biological membranes, thereby improving its absorption and distribution within the body. The ester linkage between α-tocopherol and nicotinic acid also contributes to its stability and prolonged half-life, making it a more effective and sustainable therapeutic option.

In recent years, (±)-α-tocopherol nicotinate has been extensively studied for its potential in combating oxidative stress and inflammation. Oxidative stress is a key factor in the pathogenesis of numerous chronic diseases, including cardiovascular disorders, neurodegenerative conditions, and certain types of cancer. The antioxidant activity of vitamin E, coupled with the anti-inflammatory effects of nicotinic acid, positions (±)-α-tocopherol nicotinate as a multifaceted therapeutic agent.

One of the most compelling aspects of (±)-α-tocopherol nicotinate is its role in cardiovascular health. Studies have shown that this compound can help reduce LDL cholesterol levels while increasing HDL cholesterol, thereby improving lipid profiles and reducing the risk of atherosclerosis. Additionally, its ability to scavenge free radicals and protect LDL particles from oxidation further underscores its potential in preventing cardiovascular diseases.

Neuroprotective effects have also been observed with (±)-α-tocopherol nicotinate. Oxidative damage and inflammation in the brain are implicated in the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's. Research indicates that this compound can cross the blood-brain barrier and provide neuroprotection by mitigating oxidative stress and modulating inflammatory pathways. These findings suggest that (±)-α-tocopherol nicotinate may have therapeutic benefits in preserving cognitive function and delaying the onset of neurodegenerative disorders.

The anti-inflammatory properties of (±)-α-tocopherol nicotinate have been explored in various inflammatory conditions, including rheumatoid arthritis and inflammatory bowel disease. By inhibiting pro-inflammatory cytokines and reducing oxidative damage, this compound can help alleviate symptoms and improve overall disease management. Its ability to modulate immune responses makes it a promising candidate for developing novel anti-inflammatory therapies.

In addition to its therapeutic applications, (±)-α-tocopherol nicotinate has shown potential in skin health and wound healing. Its antioxidant properties help protect skin cells from UV-induced damage and environmental pollutants, promoting skin rejuvenation and reducing signs of aging. Furthermore, its anti-inflammatory effects can accelerate wound healing by reducing inflammation and promoting tissue repair.

The bioavailability of (±)-α-tocopherol nicotinate has been a subject of extensive research due to its importance in determining therapeutic efficacy. Comparative studies have demonstrated that this derivative exhibits higher bioavailability than native α-tocopherol, primarily due to improved solubility and enhanced absorption. This makes it a more effective option for patients who require high doses of vitamin E supplementation.

Recent advancements in pharmacokinetic studies have provided deeper insights into the metabolic pathways of (±)-α-tocopherol nicotinate. These studies highlight its ability to be efficiently metabolized and excreted without significant accumulation or toxicity. This favorable pharmacokinetic profile makes it suitable for long-term therapeutic use across various populations.

The safety profile of (±)-α-tocopherol nicotinate has been thoroughly evaluated through preclinical and clinical trials. These trials have consistently shown that the compound is well-tolerated at recommended doses, with minimal side effects reported. Common adverse effects include mild gastrointestinal discomfort, which are generally transient and dose-dependent.

In conclusion, (±)-α-Tocopherol nicotinate (CAS No. 51898-34-1) is a versatile therapeutic agent with significant potential in addressing various health conditions related to oxidative stress, inflammation, and cardiovascular dysfunction. Its unique chemical structure enhances bioavailability and stability, making it an effective alternative to native vitamin E supplements. Ongoing research continues to uncover new applications for this compound, further solidifying its role as a valuable asset in modern medicine.

• 43119-47-7((R)-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl nicotinate)
• 16676-75-8((R)-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl nicotinate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)